Glenmark Pharma considers buyback of Singapore FCCBs; stock jumps 3%

Glenmark Pharma said its operations committee would consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds.

from Stocks-Markets-Economic Times https://ift.tt/2N3MKXw